A Clinical Study to Evaluate Safety and Performance of PEEK-OPTIMA™ HA Enhanced.
A Prospective, Non-comparative, Single-centre, Post-market Clinical Study to Evaluate the Safety and Performance of PEEK-OPTIMA™ HA Enhanced Interbody Cages for the Treatment of Degenerative Disc Disease in the Lumbar Spine
Sponsor: Invibio Ltd
This NA trial investigates Degenerative Disc Disease and Retrolisthesis and is currently completed. Invibio Ltd leads this study, which shows 12 recorded versions since 2021 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
12 versions recorded-
Feb 2026 — Present [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Dec 2025 — Feb 2026 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
May 2025 — Dec 2025 [monthly]
Recruiting NA
-
Sep 2024 — May 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
▶ Show 7 earlier versions
-
Oct 2023 — Jul 2024 [monthly]
Recruiting NA
-
Sep 2022 — Oct 2023 [monthly]
Recruiting NA
-
Sep 2021 — Sep 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Mar 2021 — Sep 2021 [monthly]
Not Yet Recruiting NA
-
Jan 2021 — Mar 2021 [monthly]
Not Yet Recruiting NA
-
Sep 2020 — Jan 2021 [monthly]
Not Yet Recruiting NA
-
Jul 2020 — Sep 2020 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Invibio Ltd
- Keos LLC
- Medical Metrics Diagnostics, Inc
- Technomics Research
- Viedoc Technologies
For direct contact, visit the study record on ClinicalTrials.gov .